Drug Profile
Research programme: autoimmune disease therapy - Trubion Pharmaceuticals
Alternative Names: Autoimmune disease therapy research programme - Trubion Pharmaceuticals; TRU-017Latest Information Update: 25 Jun 2009
Price :
$50
*
At a glance
- Originator Trubion Pharmaceuticals
- Class Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Autoimmune disorders
Most Recent Events
- 18 Jan 2005 Preclinical trials in Autoimmune disorders in USA (unspecified route)